Skip to content

Dr Joachim Feldges

Partner

Munich

Feldges Joachim
Dr Joachim Feldges

Partner

Munich

Joachim is partner in our IP litigation practice and heads our German life sciences group. He is a dedicated patent litigation partner and has practised complex patent litigation since more than 30 years with a particular focus on pharmaceuticals, biotechnology and medical devices. 

He represents clients in infringement and validity cases before all major patent courts, the Federal Supreme Court and the Federal Patent Court and he has advised clients for many years developing and implementing international patent litigation strategies in numerous European jurisdictions. In addition, Joachim regularly represents clients in opposition proceedings before the European Patent Office. He also represents clients in arbitration proceedings and acts as an arbitrator and mediator according to the WIPO rules in IP disputes. 

Noteworthy experience includes advising:

  • A pharmaceutical company concerning the infringement of an SPC by a generic product for the treatment of epilepsy.
  • Pfizer against a parallel importer to prevent parallel imports of a medicinal product from the EU accession countries during the paediatric extension of a supplementary protection certificate including proceedings in front of the CJEU.An innovative company of genetically engineered food additives on license agreements regarding the CRISPR technology.
  • A company in a patent dispute on offshore windparks in both patent infringement and nullity proceedings with regard to the German part of a European Patent.
  • A company producing industrial machines in the automotive industry in infringement and nullity proceedings concerning a German Patent.
  • A manufacturer of mounting machines for electronic components in a multinational patent dispute.
  • A global pharmaceutical company in a dispute on a license agreement on a bispecific antibody.

News & insights

purple and black image of a digital map

Blog Post: 07 MAY 2021

How protected are your drug formulations in your transactions?

Drug formulations are incredibly valuable to pharmaceutical businesses; however, they often get overlooked during transactions.  This can create risk for both the seller and buyer of the assets. For…

Read more
laptop sitting on desk

Publications: 07 MAY 2021

The perils of giving video evidence

If evidence is to be given remotely, via video link, from another country, be sure to check that this is permitted by the laws of that country.

Read more

News: 06 MAY 2021

Allen & Overy advises Cielo S.A. on their agreement with Facebook, Inc. to launch Facebook Pay in Brazil

Allen & Overy today announced its role in advising Cielo S.A. (Cielo), a leading electronic payments business in Brazil and in Latin America, in the drafting, negotiation, execution and delivery of…

Read more
Close view of a processor

Publications: 05 MAY 2021

Key provisions of the Draft AI Regulation

On 21 April 2021, the European Commission published its proposal for the Artificial Intelligence Regulation (the Draft AI Regulation).

Read more

Office

Munich

Allen & Overy LLP
Maximilianstraße 35
80539 Munich

View office →

Qualifications

Professional

Admitted as German Rechtsanwalt, 1987

Academic

Docteur en droit, University of Geneva, Switzerland, 1987
Diplôme d’Etudes Supérieures en Droit, University of Geneva, Switzerland, 1984


Pro-bono experience

  • Joachim is since 2018 a curator for Amref Health Africa Germany and acted as an ambassador in A&O’s global charity partnership with Amref in 2014-2016.

Recognition

Published work

  • Feldges J. (2017) Handbuch des Medizinprodukterechts, 2nd Edition
  • Feldges J., Kramer B. (2011) “Intellectual Property in the Life Sciences”, Germany, pp. 193 
  • Feldges J. (2011) „Anmerkung zum Urteil des EuGH vom 18.10.2011 C-34/10 – Brüstle/Greenpeace“, GRUR 2011, pp. 1045 
  • Feldges J, Kramer B. (2010) „Die Bestimmung des Schutzbereiches von ergänzenden Schutzzertifikaten für Arzneimittel“, Festschrift für Wolfgang von Meibom, pp. 57 
  • Feldges J. (2009) „Kann die Dosierung eines Medikamentes Grundlage einer patentfähigen Erfindung sein?“ Festschrift für Thomas Reimann, pp. 91 
  • Feldges J., Kramer B. (2009) “Patent Law, in Business Laws of Germany”, 2009 ed., p. 197-305. 
  • Feldges J. (2007) „Die Durchsetzung von Patenten in europäischen Streitigkeiten“, Festschrift für Tilman Schilling, pp. 111 
  • Feldges J., Kramer B. (2007) “Co-ownership of Patents under German Law, Journal of Intellectual Property Law & Practice”, pp. 742 
  • Kilger, Feldges, Jaenichen (2005) “The Erosion of Compound Protection In Germany”, Journal of the Patent and Trademark Office Society Vol. 87, pp. 569 
  • Feldges J. (2005) „Ende des absoluten Stoffschutzes? Zur Umsetzung der Biotechnologie-Richtlinie“, GRUR 2005, pp. 977 
  • Feldges J., Kanz C. (2003) in: Anhalt/Dieners, Handbuch des Medizinprodukterechts, § 25 Schutz von Medizinprodukten durch technische Schutzrechte, Munich